Is GE HealthCare Stock a Good Investment?
GE HealthCare Investment Advice | GEHC |
- Examine GE HealthCare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research GE HealthCare's leadership team and their track record. Good management can help GE HealthCare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact GE HealthCare's business and its evolving consumer preferences.
- Compare GE HealthCare's performance and market position to its competitors. Analyze how GE HealthCare is positioned in terms of product offerings, innovation, and market share.
- Check if GE HealthCare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about GE HealthCare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GE HealthCare Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GE HealthCare Technologies is a good investment.
Sell | Buy |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine GE HealthCare Stock
Researching GE HealthCare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 88.0% of the company shares are owned by institutional investors. The book value of GE HealthCare was currently reported as 18.48. The company has Price/Earnings To Growth (PEG) ratio of 2.39. GE HealthCare Techno last dividend was issued on the 14th of January 2025.
To determine if GE HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GE HealthCare's research are outlined below:
| GE HealthCare Techno is unlikely to experience financial distress in the next 2 years | |
| Over 88.0% of the company shares are owned by institutional investors | |
| On 14th of February 2025 GE HealthCare paid 0.035 per share dividend to its current shareholders | |
| Latest headline from zacks.com: GE HealthCare Technologies is a Top-Ranked Value Stock Should You Buy |
GE HealthCare Quarterly Cost Of Revenue |
|
GE HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GE HealthCare Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GE HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact GE HealthCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises GE HealthCare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-10-31 | 2023-09-30 | 0.9 | 0.99 | 0.09 | 10 | ||
2024-02-06 | 2023-12-31 | 1.07 | 1.18 | 0.11 | 10 | ||
2025-02-13 | 2024-12-31 | 1.2634 | 1.45 | 0.1866 | 14 | ||
2023-01-30 | 2022-12-31 | 1.06 | 1.31 | 0.25 | 23 |
GE HealthCare Target Price Consensus
GEHC target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. GE HealthCare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 20 | Strong Buy |
Most GEHC analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand GEHC stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of GE HealthCare Techno, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGE HealthCare Target Price Projection
GE HealthCare's current and average target prices are 90.81 and 96.76, respectively. The current price of GE HealthCare is the price at which GE HealthCare Technologies is currently trading. On the other hand, GE HealthCare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
GE HealthCare Market Quote on 25th of February 2025
Target Price
Analyst Consensus On GE HealthCare Target Price
GE HealthCare Analyst Ratings
GE HealthCare's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about GE HealthCare stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of GE HealthCare's financials, market performance, and future outlook by experienced professionals. GE HealthCare's historical ratings below, therefore, can serve as a valuable tool for investors.GE HealthCare's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 41.42 B.Market Cap |
|
GE HealthCare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.15 | |
| Return On Capital Employed | 0.11 | 0.14 | |
| Return On Assets | 0.06 | 0.08 | |
| Return On Equity | 0.24 | 0.15 |
Determining GE HealthCare's profitability involves analyzing its financial statements and using various financial metrics to determine if GE HealthCare is a good buy. For example, gross profit margin measures GE HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GE HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of GE HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GE HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of GE HealthCare's management manipulating its earnings.
Evaluate GE HealthCare's management efficiency
GE HealthCare Techno has return on total asset (ROA) of 0.0577 % which means that it generated a profit of $0.0577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2569 %, meaning that it created $0.2569 on every $100 dollars invested by stockholders. GE HealthCare's management efficiency ratios could be used to measure how well GE HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, GE HealthCare's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.08, whereas Return On Equity is forecasted to decline to 0.15. At present, GE HealthCare's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 1.2 B, whereas Total Assets are forecasted to decline to about 31.6 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 18.97 | 27.46 | |
| Tangible Book Value Per Share | (12.20) | (12.81) | |
| Enterprise Value Over EBITDA | 9.35 | 7.62 | |
| Price Book Value Ratio | 4.22 | 2.48 | |
| Enterprise Value Multiple | 9.35 | 7.62 | |
| Price Fair Value | 4.22 | 2.48 | |
| Enterprise Value | 30 B | 26.6 B |
Examining the leadership quality of GE HealthCare Technologies offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Basic technical analysis of GEHC Stock
As of the 25th of February, GE HealthCare owns the Semi Deviation of 1.07, standard deviation of 1.69, and Market Risk Adjusted Performance of 0.2201. GE HealthCare Technologies technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.GE HealthCare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GE HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on GE HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GE HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GE HealthCare's Outstanding Corporate Bonds
GE HealthCare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GE HealthCare Techno uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GEHC bonds can be classified according to their maturity, which is the date when GE HealthCare Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US36262BAA08 Corp BondUS36262BAA08 | View | |
| HLNLN 3125 24 MAR 25 Corp BondUS36264NAB01 | View | |
| HLNLN 3625 24 MAR 32 Corp BondUS36264FAM32 | View | |
| HLNLN 3375 24 MAR 29 Corp BondUS36264FAL58 | View | |
| HLNLN 4 24 MAR 52 Corp BondUS36264FAN15 | View | |
| HLNLN 3375 24 MAR 27 Corp BondUS36264FAK75 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand GE HealthCare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing GE HealthCare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0794 | |||
| Market Risk Adjusted Performance | 0.2201 | |||
| Mean Deviation | 1.11 | |||
| Semi Deviation | 1.07 | |||
| Downside Deviation | 1.2 | |||
| Coefficient Of Variation | 995.55 | |||
| Standard Deviation | 1.69 | |||
| Variance | 2.84 | |||
| Information Ratio | 0.0974 | |||
| Jensen Alpha | 0.1631 | |||
| Total Risk Alpha | 0.1705 | |||
| Sortino Ratio | 0.1363 | |||
| Treynor Ratio | 0.2101 | |||
| Maximum Drawdown | 10.18 | |||
| Value At Risk | (1.73) | |||
| Potential Upside | 2.89 | |||
| Downside Variance | 1.45 | |||
| Semi Variance | 1.15 | |||
| Expected Short fall | (1.31) | |||
| Skewness | 2.15 | |||
| Kurtosis | 9.9 |
| Risk Adjusted Performance | 0.0794 | |||
| Market Risk Adjusted Performance | 0.2201 | |||
| Mean Deviation | 1.11 | |||
| Semi Deviation | 1.07 | |||
| Downside Deviation | 1.2 | |||
| Coefficient Of Variation | 995.55 | |||
| Standard Deviation | 1.69 | |||
| Variance | 2.84 | |||
| Information Ratio | 0.0974 | |||
| Jensen Alpha | 0.1631 | |||
| Total Risk Alpha | 0.1705 | |||
| Sortino Ratio | 0.1363 | |||
| Treynor Ratio | 0.2101 | |||
| Maximum Drawdown | 10.18 | |||
| Value At Risk | (1.73) | |||
| Potential Upside | 2.89 | |||
| Downside Variance | 1.45 | |||
| Semi Variance | 1.15 | |||
| Expected Short fall | (1.31) | |||
| Skewness | 2.15 | |||
| Kurtosis | 9.9 |
Consider GE HealthCare's intraday indicators
GE HealthCare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GE HealthCare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GE HealthCare Corporate Filings
F4 | 19th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 30th of January 2025 Other Reports | ViewVerify | |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
GEHC Stock media impact
Far too much social signal, news, headlines, and media speculation about GE HealthCare that are available to investors today. That information is available publicly through GEHC media outlets and privately through word of mouth or via GEHC internal channels. However, regardless of the origin, that massive amount of GEHC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GE HealthCare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GE HealthCare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GE HealthCare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GE HealthCare alpha.
GE HealthCare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards GE HealthCare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
GE HealthCare Techno Historical Investor Sentiment
Investor biases related to GE HealthCare's public news can be used to forecast risks associated with an investment in GEHC. The trend in average sentiment can be used to explain how an investor holding GEHC can time the market purely based on public headlines and social activities around GE HealthCare Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GE HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GE HealthCare and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average GE HealthCare news discussions. The higher the estimate score, the more favorable the investor's outlook on GE HealthCare.
GE HealthCare Maximum Pain Price Across April 17th 2025 Option Contracts
GE HealthCare's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of GE HealthCare close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of GE HealthCare's options.
GE HealthCare Corporate Executives
Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Saccaro | VP CFO | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.784 | Dividend Share 0.125 | Earnings Share 4.34 | Revenue Per Share | Quarterly Revenue Growth 0.022 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between GE HealthCare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.